Elanco Animal Health (ELAN) Current Assets (2017 - 2026)
Elanco Animal Health (ELAN) posted Current Assets of $3.6 billion for Q1 2026, up 3.64% sequentially from $3.5 billion in Q4 2025, and up 4.19% YoY from $3.4 billion in Q1 2025.
Elanco Animal Health (ELAN) Current Assets (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Current Assets for 10 years, with the latest figure at $3.6 billion in Q1 2026.
- Quarterly Current Assets rose 4.19% year-over-year to $3.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 billion (up 4.19% YoY) and the FY2025 annual result came in at $3.5 billion, up 7.56% from the prior year.
- Current Assets climbed to $3.6 billion in Q1 2026 per ELAN's latest filing, from $3.5 billion in the prior quarter.
- Over five years, Current Assets peaked at $4.0 billion in Q1 2024 and troughed at $3.2 billion in Q3 2022.
- A 5-year average of $3.5 billion and a median of $3.5 billion in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets grew 14.15% in 2024, then dropped 15.06% in 2025.
- Over 5 years, Current Assets stood at $3.3 billion in 2022, then gained by 3.9% to $3.4 billion in 2023, then fell by 5.64% to $3.2 billion in 2024, then increased by 7.56% to $3.5 billion in 2025, then grew by 3.64% to $3.6 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $3.6 billion, $3.5 billion, and $3.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.80 Bn |
| Mar 31, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.46 Bn |
| Sep 30, 2025 | 3.49 Bn |
| Jun 30, 2025 | 3.61 Bn |
| Mar 31, 2025 | 3.44 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Sep 30, 2024 | 3.37 Bn |
| Jun 30, 2024 | 4.01 Bn |
| Mar 31, 2024 | 4.05 Bn |
| Dec 31, 2023 | 3.41 Bn |
| Sep 30, 2023 | 3.57 Bn |
| Jun 30, 2023 | 3.65 Bn |
| Mar 31, 2023 | 3.55 Bn |
| Dec 31, 2022 | 3.28 Bn |
| Sep 30, 2022 | 3.15 Bn |
| Jun 30, 2022 | 3.31 Bn |
| Mar 31, 2022 | 3.19 Bn |
| Dec 31, 2021 | 3.27 Bn |
| Sep 30, 2021 | 3.16 Bn |